Direkt zum Inhalt
Merck
  • Small intestinal transplant mucosal necrosis associated with enteral sodium polystyrene sulfonate administration.

Small intestinal transplant mucosal necrosis associated with enteral sodium polystyrene sulfonate administration.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons (2012-08-21)
M Saginur, A Thiesen, A Lacson, D Bigam, J Yap
PMID22900907
ZUSAMMENFASSUNG

Diarrhea is a common manifestation of disease in recipients of intestinal transplants. Sodium Polystyrene Sulfonate administration has been associated with significant bowel injury. Recognizing the diagnosis requires clinical awareness and comprehensive review of intestinal biopsies. We present an illustrative case and discussion. It is the first reported case in a pediatric intestinal transplant patient with serial intestinal biopsies documenting the evolution of disease.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung
243051
Sigma-Aldrich
Poly(natrium-4-styrolsulfonat), average Mw ~70,000
561223
Sigma-Aldrich
Poly(4-styrolsulfonsäure) -Lösung, Mw ~75,000, 18 wt. % in H2O
434574
Sigma-Aldrich
Poly(natrium-4-styrolsulfonat), average Mw ~1,000,000, powder
527483
Sigma-Aldrich
Poly(natrium-4-styrolsulfonat) -Lösung, average Mw ~70,000, 30 wt. % in H2O
561967
Sigma-Aldrich
Poly(natrium-4-styrolsulfonat) -Lösung, average Mw ~200,000, 30 wt. % in H2O
527491
Sigma-Aldrich
Poly(natrium-4-styrolsulfonat) -Lösung, average Mw ~1,000,000, 25 wt. % in H2O